These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12457032)

  • 1. Clinical application of oligonucleotide probe array for full-length gene sequencing of TP53 in colon cancer.
    Takahashi Y; Ishii Y; Nagata T; Ikarashi M; Ishikawa K; Asai S
    Oncology; 2003; 64(1):54-60. PubMed ID: 12457032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.
    Lu ML; Wikman F; Orntoft TF; Charytonowicz E; Rabbani F; Zhang Z; Dalbagni G; Pohar KS; Yu G; Cordon-Cardo C
    Clin Cancer Res; 2002 Jan; 8(1):171-9. PubMed ID: 11801555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
    Chiaretti S; Tavolaro S; Marinelli M; Messina M; Del Giudice I; Mauro FR; Santangelo S; Piciocchi A; Peragine N; Truong S; Patten N; Ghia EM; Torrente I; De Propris MS; Nanni M; Lawrence J; Guarini A; Foà R
    Genes Chromosomes Cancer; 2011 Apr; 50(4):263-74. PubMed ID: 21319261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis.
    Wen WH; Bernstein L; Lescallett J; Beazer-Barclay Y; Sullivan-Halley J; White M; Press MF
    Cancer Res; 2000 May; 60(10):2716-22. PubMed ID: 10825146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of TP53 germline mutations in pediatric tumor patients using DNA microarray-based sequencing technology.
    Schaefer KL; Wai D; Poremba C; Diallo R; Boecker W; Dockhorn-Dworniczak B
    Med Pediatr Oncol; 2002 Apr; 38(4):247-53. PubMed ID: 11920788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array.
    Ahrendt SA; Halachmi S; Chow JT; Wu L; Halachmi N; Yang SC; Wehage S; Jen J; Sidransky D
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7382-7. PubMed ID: 10377423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in tumour suppressor gene p53 correlate with inhibition of thrombospondin-1 gene expression in colon cancer cells.
    Tokunaga T; Nakamura M; Oshika Y; Tsuchida T; Kazuno M; Fukushima Y; Kawai K; Abe Y; Kijima H; Yamazaki H; Tamaoki N; Ueyama Y
    Virchows Arch; 1998 Nov; 433(5):415-8. PubMed ID: 9849855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines.
    Xu L; Davidson BJ; Murty VV; Li RG; Sacks PG; Garin-Chesa P; Schantz SP; Chaganti RS
    Int J Cancer; 1994 Nov; 59(3):383-7. PubMed ID: 7927946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of aberrations of 17p and p53 gene in gastrointestinal cancers by dual (two-color) fluorescence in situ hybridization and GeneChip p53 assay.
    Takahashi Y; Nagata T; Asai S; Shintaku K; Eguchi T; Ishii Y; Fujii M; Ishikawa K
    Cancer Genet Cytogenet; 2000 Aug; 121(1):38-43. PubMed ID: 10958939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of oligonucleotide arrays for sequencing of the p53 gene in DNA from formalin-fixed, paraffin-embedded breast cancer specimens.
    Cooper M; Li SQ; Bhardwaj T; Rohan T; Kandel RA
    Clin Chem; 2004 Mar; 50(3):500-8. PubMed ID: 14726466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low density DNA microarray for detection of most frequent TP53 missense point mutations.
    Rangel-López A; Maldonado-Rodríguez R; Salcedo-Vargas M; Espinosa-Lara JM; Méndez-Tenorio A; Beattie KL
    BMC Biotechnol; 2005 Feb; 5():8. PubMed ID: 15713227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective study.
    Fouquet C; Antoine M; Tisserand P; Favis R; Wislez M; Commo F; Rabbe N; Carette MF; Milleron B; Barany F; Cadranel J; Zalcman G; Soussi T
    Clin Cancer Res; 2004 May; 10(10):3479-89. PubMed ID: 15161705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis.
    Thorlacius S; Thorgilsson B; Björnsson J; Tryggvadottir L; Börresen AL; Ogmundsdottir HM; Eyfjörd JE
    Eur J Cancer; 1995 Oct; 31A(11):1856-61. PubMed ID: 8541113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
    Berns EM; Foekens JA; Vossen R; Look MP; Devilee P; Henzen-Logmans SC; van Staveren IL; van Putten WL; Inganäs M; Meijer-van Gelder ME; Cornelisse C; Claassen CJ; Portengen H; Bakker B; Klijn JG
    Cancer Res; 2000 Apr; 60(8):2155-62. PubMed ID: 10786679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the TP53 gene in laser-microdissected glioblastoma vasculature.
    Kulla A; Burkhardt K; Meyer-Puttlitz B; Teesalu T; Asser T; Wiestler OD; Becker AJ
    Acta Neuropathol; 2003 Apr; 105(4):328-32. PubMed ID: 12624785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harmonized microarray/mutation scanning analysis of TP53 mutations in undissected colorectal tumors.
    Favis R; Huang J; Gerry NP; Culliford A; Paty P; Soussi T; Barany F
    Hum Mutat; 2004 Jul; 24(1):63-75. PubMed ID: 15221790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 mutations in astrocytic gliomas: an association with histological grade, TP53 codon 72 polymorphism and p53 expression.
    Faria MH; Neves Filho EH; Alves MK; Burbano RM; de Moraes Filho MO; Rabenhorst SH
    APMIS; 2012 Nov; 120(11):882-9. PubMed ID: 23009112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers.
    Costa A; Marasca R; Valentinis B; Savarino M; Faranda A; Silvestrini R; Torelli G
    J Pathol; 1995 May; 176(1):45-53. PubMed ID: 7616356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
    Fujii S; Fujimori T; Chiba T
    J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.